Skip to main content

ConvaTec Group PLC Value Stock - Dividend - Research Selection

ConvaTec Group PLC

ISIN: GB00BD3VFW73, WKN: A2AUD3

Market price date: 24.05.2021
Market price: 230,40 USD




ConvaTec Group PLC Fundamental data and company key figures of the share

Annual reports in USD
Key figures 08-03-2021
Cash flow
Net operating cash flow 399.500.000
Capital Expenditures -86.200.000
Free cash flow 313.300.000
Balance sheet
Total Equity 1.670.700.000
Liabilities & Shareholders equity 3.766.500.000
Income statement
Net income 112.500.000
Eps (diluted) 0,056
Diluted shares outstanding 2.004.350.000
Net sales/revenue 1.894.300.000

Fundamental ratios calculated on: 24-05-2021

Ratios
Key figures 24-05-2021
Cash flow
P/C 1.158,96
   
P/FC 1.477,83
Balance sheet
ROI2,99
ROE44,36
Income statement
P/E4.115,59
Div. Yield0,00%
P/B277,13
P/S244,42


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolCTEC.L
Market Capitalization463.004.860.416,00 USD
Country
IndicesNO INDEX
Sectors
Raw Data SourceIFRS in Millionen USD
Stock Split
Internetconvatecgroup.com


Description of the company

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets. Its products include FlexiSeal Signal, FlexiSeal Fecal Collector and Intermittent Catheters.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, convatecgroup.com